In addition, a subpopulation of hepatocellular carcinomas and adenomas are also known to express OATP1B3, resulting in significant tumor enhancement on gadoxetic acid-enhanced MRIs [16, 17]. This evidence concerns the gene SLCO1B3 and hepatocellular carcinoma.